V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192158 | 20123871 | null | 52 | Adjuvant (A) | 2020-11-14 | 2020-11-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101203818 |
| 20192159 | 20123872 | 1.51 | 62 | Neo-adjuvant (N) | 2020-05-12 | 2020-05-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100935436 |
| 20192160 | 20123873 | 1.91 | 49.7 | Palliative (P) | 2019-06-13 | 2019-07-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100351961 |
| 20192163 | 20123874 | 1.84 | 89 | null | 2018-07-26 | 2018-07-30 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101087826 |
| 20192164 | 20123875 | 1.54 | 71 | null | 2018-11-01 | 2019-04-30 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100463170 |
| 20192166 | 20123876 | 1.9 | 100.4 | Palliative (P) | 2016-01-02 | 2016-09-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100193285 |
| 20192169 | 20123877 | 1.74 | 79.6 | Palliative (P) | 2017-01-13 | 2017-01-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100620997 |
| 20192183 | 20123878 | 1.76 | 45.1 | null | 2019-07-28 | 2019-09-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101326580 |
| 20192184 | 20123879 | 1.78 | 45.05 | null | 2017-02-04 | 2017-02-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100935048 |
| 20192188 | 20123880 | 1.59 | 95.2 | 03 | 2016-03-13 | 2016-03-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100660987 |
| 20192190 | 20123881 | 1.67 | 62.3 | null | 2022-03-03 | 2022-03-12 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101267429 |
| 20192195 | 20123882 | 1.67 | null | null | 2017-10-19 | 2017-10-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101653238 |
| 20192197 | 20123883 | 1.63 | 78 | Palliative (P) | 2019-03-02 | 2019-03-13 | Docetaxel | 02 | null | DOCETAXEL | 100163346 |
| 20192201 | 20123884 | 1.83 | 47.6 | null | 2016-04-12 | 2016-10-19 | Docetaxel | 02 | null | DOCETAXEL | 101203274 |
| 20192202 | 20123885 | 1.61 | 72 | null | 2020-04-06 | 2020-04-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101262028 |
| 20192204 | 20123886 | 1.6 | 61.5 | Palliative (P) | 2016-07-19 | 2016-07-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100137380 |
| 20192208 | 20123887 | 1.68 | 70 | Palliative (P) | 2019-04-07 | 2019-04-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101499154 |
| 20192212 | 20123888 | 1.66 | 60 | Palliative (P) | 2018-01-07 | 2018-03-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100393473 |
| 20192214 | 20123889 | 1.83 | 105.6 | Adjuvant (A) | 2017-01-07 | 2017-01-25 | Docetaxel | 02 | N | DOCETAXEL | 101592791 |
| 20192215 | 20123890 | 1.88 | 96.1 | Palliative (P) | 2017-05-07 | 2017-05-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100615193 |
| 20192216 | 20123891 | 1.82 | 55 | null | 2016-05-10 | 2016-06-09 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100391170 |
| 20192218 | 20123892 | 1.66 | 62.8 | Palliative (P) | null | 2020-02-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100655115 |
| 20192221 | 20123893 | 1.55 | 56 | Palliative (P) | 2018-09-03 | 2018-10-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101544263 |
| 20192223 | 20123894 | 1.54 | 115.9 | null | 2015-08-27 | 2016-05-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100595242 |
| 20192228 | 20123895 | 1.7 | 92 | Adjuvant (A) | 2017-02-16 | 2017-02-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100524704 |
| 20192234 | 20123896 | 1.73 | 50.4 | Palliative (P) | 2019-06-27 | 2019-07-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100998751 |
| 20192238 | 20123897 | 1.81 | 66.7 | Palliative (P) | 2018-09-30 | 2018-09-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101082969 |
| 20192239 | 20123898 | 1.52 | 62 | Palliative (P) | 2018-08-10 | 2018-08-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100928329 |
| 20192244 | 20123899 | 1.85 | 77.9 | Palliative (P) | 2019-08-07 | 2020-04-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100129435 |
| 20192245 | 20123900 | 1.53 | 74.8 | Palliative (P) | 2018-09-18 | 2018-10-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101040253 |
| 20192249 | 20123901 | 1.53 | 93.6 | Palliative (P) | 2018-07-06 | 2018-07-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100986464 |
| 20192255 | 20123902 | 1.67 | 121.8 | null | 2021-03-28 | 2021-04-01 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100162233 |
| 20192256 | 20123903 | 1.66 | 69.8 | Palliative (P) | 2018-07-09 | 2018-07-10 | Docetaxel | 02 | N | DOCETAXEL | 100003579 |
| 20192258 | 20123904 | 1.54 | 129.1 | null | 2018-03-09 | 2018-07-14 | Docetaxel | 02 | null | DOCETAXEL | 101158915 |
| 20192265 | 20123905 | 1.84 | 61.3 | Adjuvant (A) | 2019-11-21 | 2019-11-21 | Docetaxel | N | N | DOCETAXEL | 100380517 |
| 20192278 | 20123906 | 1.69 | 76.1 | Palliative (P) | 2019-06-21 | 2019-06-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100321875 |
| 20192279 | 20123907 | 1.85 | 88 | null | 2018-03-02 | 2018-03-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100152638 |
| 20192286 | 20123908 | 1.7 | 54.3 | Palliative (P) | 2020-01-22 | 2020-02-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101551776 |
| 20192288 | 20123909 | 1.88 | 79 | null | 2020-07-26 | 2020-07-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101545567 |
| 20192298 | 20123910 | 1.7 | 55.9 | null | 2017-09-05 | 2017-09-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101281206 |
| 20192306 | 20123911 | 1.74 | 67.25 | Neo-adjuvant (N) | 2017-09-20 | 2017-09-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100693372 |
| 20192310 | 20123912 | 1.52 | 50.3 | Adjuvant (A) | 2018-12-21 | 2019-03-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100301319 |
| 20192315 | 20123913 | 1.97 | 86.2 | Palliative (P) | 2020-10-05 | 2020-10-12 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101714691 |
| 20192319 | 20123914 | 1.67 | 60.6 | Adjuvant (A) | 2018-04-04 | 2018-04-12 | Docetaxel | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100918382 |
| 20192320 | 20123915 | 1.9 | 65.4 | null | 2018-07-11 | 2018-07-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101079497 |
| 20192323 | 20123916 | 1.68 | 66.8 | null | 2019-09-23 | 2019-11-19 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100943167 |
| 20192324 | 20123917 | 1.63 | 72.05 | Palliative (P) | 2016-12-20 | 2016-12-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100499086 |
| 20192328 | 20123918 | 1.51 | 81.1 | Palliative (P) | 2018-09-07 | 2018-09-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100190376 |
| 20192329 | 20123919 | 1.71 | 64.7 | Palliative (P) | 2016-02-18 | 2016-12-01 | Docetaxel | 02 | N | DOCETAXEL | 101373674 |
| 20192334 | 20123920 | 1.89 | 44.8 | Palliative (P) | 2019-10-09 | 2019-10-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101183907 |